ACHILLION PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Achillion

ACHILLION PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP 
Reminds Investors of Class Action Against Achillion
Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff
Deadline of December 9, 2013 -- ACHN 
NEW YORK, NY -- (Marketwired) -- 12/02/13 --  Levi & Korsinsky
announces that a class action lawsuit has been commenced in the
United States District Court for the District of Connecticut on
behalf of investors who purchased Achillion Pharmaceuticals, Inc.
("Achillion" or the "Company") (NASDAQ: ACHN) common stock between
August 8, 2012 and September 30, 2013. 
For more information, click here:
http://zlk.9nl.com/achillion-pharmaceuticals-achn/. 
The complaint alleges that the Company issued materially false and
misleading statements regarding the safety and suitability of its
hepatitis drug sovaprevir. In particular, it is alleged that Company
misled investors regarding the drug's interactions with other drugs
commonly administered to treat hepatitis and/or HIV; it is further
alleged that the Company misled investors by stating that elevated
liver enzymes in patients engaged in the clinical trials were
transient and related to non-drug-related factors. 
On July 1, 2013, the Company disclosed that the FDA had instituted a
hold on sovaprevir after "elevations in liver enzymes" were noted in
a Phase I healthy subject drug-drug interaction study. Then on
September 27, 2013, it was announced that the FDA was maintaining its
clinical hold on sovaprevir. Upon this news, shares of Achillion fell
over 58% to a close of $3.02 on September 30, 2013. 
If you suffered a loss in Achillion Pharmaceuticals you have until
December 9, 2013 to request that the Court appoint you as lead
plaintiff. Your ability to share in any recovery doesn't require that
you serve as a lead plaintiff. To obtain additional information,
contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by
telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit
http://zlk.9nl.com/achillion-pharmaceuticals-achn/.  
Levi & Korsinsky is a national firm with offices in New York, New
Jersey, Connecticut, and Washington D.C. The firm has extensive
expertise in prosecuting securities litigation involving financial
fraud, representing investors throughout the nation in securities and
shareholder lawsuits. Attorney advertising. Prior results do not
guarantee similar outcomes. 
CONTACT: 
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor 
New York, NY 10004 
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com 
 
 
Press spacebar to pause and continue. Press esc to stop.